Literature DB >> 3010971

A guanine nucleotide-dependent regulatory protein couples substance P receptors to phospholipase C in rat parotid gland.

C W Taylor, J E Merritt, J W Putney, R P Rubin.   

Abstract

Electrically permeabilized cells of rat parotid gland, prelabelled with [3H]-inositol, synthesized [3H]-inositol phosphates (IP3 and IP2) when stimulated with alpha 1-adrenergic, muscarinic-cholinergic, and substance P receptor-agonists. Non-hydrolyzable analogues of GTP (GTP gamma S and GppNHp) also stimulated [3H]-IP3 formation by permeabilized cells and they potentiated the stimulation by receptor-agonists. These effects of guanine nucleotides occurred only with GTP analogues and only in permeabilized cells indicating an intracellular site of action. NaF stimulated [3H]-IP3 accumulation, an effect that was not entirely attributable to the ability of F- to inhibit (1,4,5)IP3 degradation. These results suggest that a guanine nucleotide-dependent regulatory protein couples Ca2+-mobilizing receptors to phospholipase C in parotid gland.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3010971     DOI: 10.1016/0006-291x(86)90919-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  A substance P (neurokinin-1) receptor mutant carboxyl-terminally truncated to resemble a naturally occurring receptor isoform displays enhanced responsiveness and resistance to desensitization.

Authors:  H Li; S E Leeman; B E Slack; G Hauser; W S Saltsman; J E Krause; J K Blusztajn; N D Boyd
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

2.  Evidence for G proteins in rat parotid plasma membranes and secretory granule membranes.

Authors:  E L Watson; D DiJulio; D Kauffman; J Iversen; M R Robinovitch; K T Izutsu
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

3.  Further studies on the mechanism of action of substance P in rat brain, involving selective phosphatidylinositol hydrolysis.

Authors:  R E Catalán; A M Martínez; M D Aragonés; F Hernández; A Liras; B G Miguel
Journal:  Neurochem Res       Date:  1995-10       Impact factor: 3.996

4.  AlF-4 inhibits the accumulation of Ca in the endoplasmic reticulum in intact myometrial strips, but not in the rabbit ear artery.

Authors:  L Missiaen; Y Kanmura; F Wuytack; L Raeymaekers; I Declerck; G Droogmans; R Casteels
Journal:  Pflugers Arch       Date:  1989-08       Impact factor: 3.657

5.  AlF4- reversibly inhibits 'P'-type cation-transport ATPases, possibly by interacting with the phosphate-binding site of the ATPase.

Authors:  L Missiaen; F Wuytack; H De Smedt; M Vrolix; R Casteels
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

6.  Muscarinic, alpha 1-adrenergic and peptidergic agonists stimulate phosphoinositide hydrolysis and regulate mucin secretion in rat submandibular gland cells.

Authors:  N Fleming; P T Bilan; E Sliwinski-Lis; V Carvalho
Journal:  Pflugers Arch       Date:  1987-08       Impact factor: 3.657

7.  Pertussis toxin-insensitive G protein mediates substance P-induced inhibition of potassium channels in brain neurons.

Authors:  Y Nakajima; S Nakajima; M Inoue
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

8.  Effects of muscarinic, alpha-adrenergic, and substance P agonists and ionomycin on ion transport mechanisms in the rat parotid acinar cell. The dependence of ion transport on intracellular calcium.

Authors:  S P Soltoff; M K McMillian; L C Cantley; E J Cragoe; B R Talamo
Journal:  J Gen Physiol       Date:  1989-02       Impact factor: 4.086

9.  Two modes of regulation of the phospholipase C-linked substance-P receptor in rat parotid acinar cells.

Authors:  H Sugiya; J F Obie; J W Putney
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

10.  The role of substance P in myocardial dysfunction during ischemia and reperfusion.

Authors:  H Chiao; R W Caldwell
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.